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Abstract
Tracer/tracee experiments are commonly used in biochemistry. In this thesis we have ap-
plied the method to the kinetics of lipoproteins and their lipids. A short introduction to
lipoproteins is given, and the theory of multi compartmental modelling and tracer/tracee
kinetics are presented.
A compartmental model for the kinetics of apolipoprotein B-100 (apoB) and triglycerides
(TG) is presented and applied to nine normolipidemic subjects, and one IGT subject. For the
implementation of the model a commercial program called SAAMII was used. The fractional
catabolic rate, fractional transfer rate, production and the delay time for apoB and TG were
calculated. The production was  
	 grams of TG per day and  mg of apoB per
day.   of the TG and  of the apoB were secreted into the VLDL
 
subfraction.
For the TG the delay time was 	 ﬀ	ﬁﬃﬂ hours and for apoB 	 	ﬁ hours.
The aim of this thesis is to describe the mathematical model and the results.
We end the thesis by presenting how the project will be continued.
Keywords: Compartmental modelling, lipoprotein, apolipoprotein B, glycerol, triglycerides,
tracer kinetics, stable isotope.
Preface
The thesis
This licentiate thesis is the mathematical result in an ongoing project in kinetics of lipopro-
teins and lipids. The project is a collaboration between Chalmers University of Technol-
ogy, the Wallenberg laboratory for cardiovascular research at The Sahlgrenska Academy at
Go¨teborg University and the Medical Department of Helsinki University.
The thesis is also the final result of the five semester ECMI program. ECMI stands for Eu-
ropean Consortium For Mathematics in Industry and is a collaboration between universities
in Europe for a program in applied mathematics. The first two semesters of the program
consists of core courses and the next two semesters are individual courses focusing on the
upcoming project. The last semester is devoted to a mathematical project originating from
the industry.
This work was funded by NTM, Chalmers University of Technology and the Wallenberg
laboratory.
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Some biomedicine terms
  triglyceride or triacylglycerol. An ester formed by glycerol and three (identical or dif-
ferent) fatty acids.
  phospholipids. A lipid containing one or more phosphate groups. Phospholipids are
soluble in both water and lipids (amphipathic).
  lipase. Enzyme that catalyse the hydrolysis of triglyceride.
  hydrolysis. Reaction where water is added to produce two or more products.
  endocytosis. Uptake of extracellular material through the plasma membrane.
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Introduction
Lipids, such as triglycerides and cholesterol, are transported in the blood by particles called
lipoproteins. Particles that are rich in lipids have low density, but the density increase as
the particles deliver their fat. The particles are classified according to their density. Here the
very low density lipoprotein subclasses VLDL   and VLDL  are considered.
The aim of this thesis is to present a mathematical model that describes the kinetics of
lipoproteins and triglycerides in the VLDL   and VLDL  subfractions. First an introduc-
tion to lipoproteins and especially to VLDL   and VLDL  metabolism is given. The theory of
multi compartmental modelling, and tracer kinetics is shortly presented.
The kinetics of the particles are measured by measuring the kinetics of a protein molecule,
called apolipoprotein B (apoB), attached to the particle. A compartmental model where apoB
and TG are coupled is presented and applied to nine normolipidemic subjects and one IGT
subject. The project is an ongoing work to develop a model that is applicable to normolipi-
demics, IGTs and subjects with type-2 diabetes. A time dependent model for a study where
the subjects are given a constant injection of insulin will also be developed in the continua-
tion of the project. This will give good statistical material to analyse the effects of insulin on
secretion and composition of VLDL   and VLDL  particles.
Compartmental models have been used to model apoB (for instance [6], [8], [9] and [10]) and
TG [16]. But they have never been modelled simultaneously before. The fundamental base
of the model is an apoB model used in several studies, among others [6], [8], [9] and [10].
The possible applications of the model are abundant, not only in studies on diabetes but also
in sports science and nutrition.
The author want to point out that his work at this point is mainly to derive the model, not to
draw conclusions about the underlying biochemistry.
The study of lipoproteins and cholesterol is of great importance to research concerning coro-
nary heart diseases and type-2 diabetes. Type-2 diabetes is a common disease in our soci-
ety today, and the number of people suffering from this is increasing rapidly. Changes in
lipoprotein metabolism are one of the early symptoms. The project is done in collaboration
with Assoc. Professor Jan Bore´n, director of the Wallenberg laboratory for cardiovascular
research at The Sahlgrenska Academy at Go¨teborg University and Professor Marja-Riitta
Taskinen at the Department for Medicine, University of Helsinki. The data was collected
and analysed in Helsinki and the enrichments were analysed in the Royal Infirmary Univer-
sity Hospital in Glasgow.
vii
Chapter 1
Lipoproteins and their metabolism
Here is a short introduction to lipoproteins. It is not an attempt to fully describe the lipopro-
tein metabolism, but contains the most essential information needed to model the kinetics
of lipoproteins and triglycerides. For further reading for instance [14] or [15] are recom-
mended.
Lipids are not soluble in water, because they are hydrophobic. The particles transporting
lipids and cholesterol in the blood are called lipoproteins. The core of the lipoproteins con-
sists of triglycerides (TG) and cholesterol-esters. The shell is a mono-layer of amphipathic
phospholipids. On the surface, proteins called apolipoproteins (see figure 1.1) are attached,
which give the lipoproteins different characteristics. Lipoproteins are classified, depending
on their different apolipoprotein content and on their density. Smaller particles have smaller
TG content and therefore have higher density because lipids have lower density than pro-
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Phospholipids and cholesterol
Triglycerides
Choletserol ester
Apolipoprotein
Apolipoprotein
Figure 1.1: Structure of lipoproteins
1
2 CHAPTER 1. LIPOPROTEINS AND THEIR METABOLISM
teins.
The largest, and most TG-rich particles are called chylomicrons (Chyl). They are synthe-
sised in the small-intestine and have a short residence time of about 30 minutes in the blood.
Two types of lipoproteins are synthesised in the liver. High density lipoproteins (HDL) and
the lipoproteins containing apoB-100. These apoB-100 containing lipoproteins are further
divided into very low, intermediate and low density lipoproteins (VLDL, IDL and LDL) ac-
cording to their density.
The three main types of lipoproteins differ not only in size and density, but also in their
metabolism. The metabolism is governed by the different apolipoproteins attached to the
particle. Chylomicrons have one molecule of apolipoprotein B-48 (apoB-48), while VLDL,
IDL and LDL have one molecule of apoB-100, giving the (VL-I-L)DL and chylomicrons
different metabolism. The apoB-48 and apoB-100 are identical up to the first 48  of the
amino-acids. The apoB-100 molecule consists of 4536 amino acids, and is one of the largest
protein-structures in humans. Some of the other apolipoproteins can be transferred between
lipoproteins. For instance apoC can be transferred between HDL and VLDL.
This paper focus on VLDL metabolism and if nothing else is mentioned lipoproteins means
the VLDL, IDL and LDL and apoB means apoB-100. To get a better discrimination be-
tween particles the VLDL fraction is further subdivided into VLDL   and VLDL  , having
VLDL   ranging from 400 to 60 Sf and VLDL  from 60 to 20 Sf. Sf, Svedberg flotation unit, is
a measure of the rotational velocity needed to make a particle float, this is proportional to the
density. It has been shown [10], [6] that there are metabolic differences between VLDL   and
VLDL  .
It should be pointed out that there is a continuous spectrum of densities within each sub-
fraction of lipoproteins.
Chyl VLDL IDL LDL HDL
density g/ml   0.95 0.95-1.006 1.006-1.019 1.019-1.063 1.063-1.21
density  20-400 12-20 0-12
diameter nm 80-100 30-80 25-30 20-25 8-13
TG content  90-95 50-65 25-40 4-6 7
CE  2-4 8-14 20-35 34-35 10-20
FC  1 4-7 7-11 6-15 5
PL  2-6 12-16 16-24 22-26 25
protein  1-2 5-10 12-16 22-26 45
major proteins A-I (31) C (40-50) B-100 (60-80) B-100 (  95) A-I (65)
 of total C (32) B-100(30-40) C (10-20) C (   1) A-II (10-23)
protein E (10) E (10-15) E (10-15) E (   1) C (5-15)
B-48 (5-8) E (1-3)
Table 1.1: The different lipoproteins and their typical compositions. CE, cholesterol ester; FC, free
cholesterol; PL, phospholipid.
1.1. SECRETION OF LIPOPROTEINS 3
1.1 Secretion of lipoproteins
VLDL particles are synthesised in the liver. Viewed in the perspective of apoB, first one
molecule of apoB is synthesised and after that TG is added until the particle is big enough. A
small fraction of these particles are secreted from the liver into the IDL and LDL subfractions.
Once in the bloodstream, the lipoprotein gradually looses its TG content and becomes an IDL
particle. Ultimately the particle becomes an LDL particle.
LIVER
IDL
LDL
PSfrag replacements
 
 	

Figure 1.2: Most of the apoB containing lipoproteins are secreted in the VLDL  and
VLDL  subfractions.
1.2 Lipoprotein metabolism
VLDL particles contain one apoB molecule but also apolipoprotein C and E (apoC and apoE).
VLDL particles lose their TG content as the apoC activates the LPL in the capillaries of the
peripheral tissues. As the hydrolysis continues, the density increases and the particle becomes
an IDL particle. IDL particles have two fates. Either they may undergo further hydrolysis
under the action of HTGL, loose their apoC and apoE to HDL and produce a cholesterol-rich
LDL particle. Or, the IDL might be catabolised by endocytosis as the apoB and apoE allow the
particles to bind to LDL-receptors. This is not possible for the larger VLDL particles, proba-
bly because of the larger size. Figure 1.2 shows a schematic view of lipoprotein metabolism.
The LDL are rich in cholesterol and are commonly known as ”bad cholesterol” (i.e. athero-
genic lipoproteins). The HDL is the ”good cholesterol”. The LDL particles can be further
subdivided, in terms of density, into LDL I, II and III. These are in two pools LDL-  and
LDL-  , which arise from different sources. Particles secreted into VLDL   becomes an LDL- 
particle and the LDL-  particles arise from particles secreted into the VLDL

, IDL and LDL
subfractions, as shown in figure 1.4. The LDL particles contain no or very little apoC and
apoE.
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Figure 1.3: Schematic view of lipoprotein metabolism
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Figure 1.4: Kinetic evidence suggests that the two metabolically distinct pools in LDL (  
and  ) arise from different sources. Pool   is the major species detected in subjects with
low to normal plasma triglyceride (TG) levels. LDL with the kinetic properties of pool
 result from delipidation of VLDL  . The two LDL species have substantially different
residence times (RT) in the circulation. LDL-III generation is favored when the plasma
triglyceride level is  mmol/l. As plasma triglyceride levels rise, VLDL  accumulate
because of overproduction or defective removal. The action of HL removes lipid from the
LDL-II to form LDL-III. CE, cholesterol ester; CETP, cholesterol ester transfer protein; PL,
phospholipids.
1.2. LIPOPROTEIN METABOLISM 5
1.2.1 VLDL
 
and VLDL

metabolism
All particles in the VLDL
 
fraction come directly from the liver. A VLDL
 
particle can either
be converted to VLDL  under the action of LPL or it can be consumed by catabolism. The
VLDL  particles come from two sources, the VLDL   and the liver. The different metabolisms
of VLDL

secreted from the liver and VLDL

derived from VLDL
 
[10], [6] suggest that
there are two different pathways for VLDL  , as shown in figure 1.5. The residence time for
VLDL   is 1-4 hours and for VLDL  3-7 hours.
When modelling the metabolism it is assumed that particles have fixed densities or sizes,
e.g. a particle can only have a fixed number of different densities. It is important to keep in
mind that there is a continuous spectrum of densities, and that hydrolysis is a process that
slowly decrease the TG content. The number of possible density classes could of course be
increased, which may be more accurate since the particle density spectrum is not discrete.
VLDL could be divided in three or four groups instead of two. Under the same assumption
that the initial particle size affects its kinetics a model as in figure 1.6 could be considered.
The model that have been developed are somewhere in between these two examples. There
is a question of how well things can be measured in order to adjust the unknown param-
eters. To get accurate measurements a certain amount of blood is needed for each fraction
and hence a large quantity of blood is needed to get many fractions. The complexity of the
model is therefore limited by the number of fractions that can be measured.
The primary goal was to develop a VLDL   and VLDL  model for apoB and TG in nor-
mal subjects. The main difference in metabolism of VLDL  secreted direct from liver and
VLDL

derived from VLDL
 
becomes most apparent in the LDL subfraction. Therefore only
one pathway for VLDL  particles are needed to model VLDL   and VLDL  .
VLDL2
LIVER
VLDL1
Figure 1.5: Schematic view of VLDL  and VLDL  metabolism
6 CHAPTER 1. LIPOPROTEINS AND THEIR METABOLISM
VLDL2
LIVER
VLDL1
Figure 1.6: Schematic view of suggested 4-level VLDL metabolism. Catabolism of newly
secreted particles are not direct but via a remnant group of particles from which they are
removed.
Chapter 2
Multi compartmental modelling
When modelling biological, chemical and physiological experiments ordinary and/or par-
tial differential equations (ODE, PDE) are often used to describe the experiment. For in-
stance one can describe the kinetic of lipoprotein particles by an ODE system. Let   be the
number of apoB molecules in the liver, and  , 	
 and  be number of apoB molecules
in VLDL, IDL and LDL respectively. The input of new particles into the liver is  (as
described later, this liver model is an oversimplification). The transfer rates of particles be-
tween liver and VLDL, VLDL and IDL and IDL and LDL are denoted   ,    and 

. There
may also be losses by direct catabolism of particles; denote these by ﬁﬀ where ﬃﬂ ! " 	 $# .
The equations describing the change of number of particles are
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3 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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A way to obtain these equations is multi compartmental modelling. Multi compartmental mod-
elling is commonly used in biochemistry and [11] is recommended for further reading. For
a more mathematical description [1] or chapter 8 in [12] gives a good introduction. The
following definitions can be found in [1] or [12].
Definition 1 (Compartment). A compartment is a well-mixed and kinetically homogeneous
amount of material. A multi compartmental system is a finite set of compartments that
interact by exchanging material. A multi compartment model is the mathematical equations
describing the fluxes of material.
A compartment does not necessary correspond to a physical volume. In a chemical reaction
with substance 7 and 8 , 7:9;8=<>7ﬁ8 one compartment may represent free mass of 7 and
one compartment the mass of A bound to 7ﬁ8 .
Definition 2 (Fractional transfer coefficient). The fraction of material transferred from com-
partment 	 to compartment # per time unit is called the fractional transfer coefficient and is
denoted ?5#@ 	3 or ?-A 

. The flux from compartment 	 to compartment # is denoted
BDCFEHG
5#I 	30ﬂJ?5#@ 	3LK
 , where K  is the mass in compartment 	 .
7
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 k(1,2)
 k(3,2) k(2,1)
 k(0,3)
 U(1)
Figure 2.1: A 3-compartment example.
A compartmental model is often described graphically by circles or boxes (compartments)
and arrows (fluxes) connecting the circles, as in figure 2.1. Throughout this thesis K  or

 are used for the amount of material in a compartment 	 . Loss from a compartment 	
(not to other compartments) is described as a flux to the environment (or a compartment
0), and the corresponding fractional transfer coefficient is ?   . External input of material
to compartment 	 is denoted E   . The equation for the rate of change of material in a
compartment 	 in an  compartment system is
)
K


)

ﬂ


A
 
A
	

?


A   K A *


A
A
	

?-A


  K

9
E

 	 (2.1)
Define ?    ﬂ *

A
A
	

?-A


   ,
)
K


)

ﬂ


A
 
?


A   K A 9
E

 	 (2.2)
The resulting system can be formulated as
)
 
)

ﬂ      9+ (2.3)
Definition 3 (Linear multi compartmental models). A multi compartmental model of 
compartments is linear if all ?A   are constants or depend on time only.
For linear models (which are the most common) it is often useful to write the input +
as   , where  is an  by  matrix and ﬁﬀﬃﬂ . The reason is that the input to one
compartment may be a linear combination of more than one input. An input may go to
more than one compartment in an unknown proportion, but in most cases the matrix 
consists of 0s and 1s.  is called the input distribution matrix.
Definition 4 (Steady-state). A multi compartmental model  !#"%$'&
 ($
ﬂ)4   9*+ is in
steady-state if the input  and  are independent of time, and the change of masses is 0.
The resulting equation in a steady-state model is
*+ ﬂ , 	 (2.4)
In experiments samples are taken at compartments, or cluster of compartments. For obvious
reasons it is not always possible to sample all compartments. The function that is sampled
is -L ﬂ/.0  . If the samples are taken at  places -*1ﬀ ﬂ and . is an  by  matrix. A
more general definition can be made with the definition of an output.
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Definition 5 (Output). An output is a linear combination of compartments connected to a
recording device. The function   ﬂ 

  is used to describe an output,   is a vector of
size  . If there are  outputs these are numbered    ﬂ 


 
 	ﬂ  	 	 	! ( .
Note. . ﬂ

     
ﬂ


, but the latter definition is more general since the sampling of the outputs
are not necessarily done at the same time points.
The equations are
 
)

ﬂ 4    9    (2.5)
  >ﬂ  


 
 	ﬂ  	 	 	! (
Both equation (2.3) and (2.5) are used to describe the system.
2.1 Properties of the systems
From equation (2.1) and (2.2) some properties of the system (2.3) can be formulated. For the
matrix  the following holds
i) Every diagonal element is non-positive ( ?   
	  ).
ii) Every off diagonal element is non-negative ( ?


A   #ﬂ 	 ).
iii) The column sums are non-positive ( *H?    	  ).
Definition 6 (Compartmental matrix). A matrix satisfying i)-iii) is called a compartmental
matrix.
Definition 7 (Exit). A compartment 	 having ?     is called an exit.
Let E denote the set of exits. A (directed) graph of a  by  matrix  is a set of  nodes, con-
nected by arrows. Two nodes 	 and # are connected with an arrow from 	 to # if  	  $# ﬂ  .
Definition 8 (Reachable). A compartment # is reachable from a compartment 	 if the graph
of 

contains a path between 	 and # .
For a compartment 	 the set of reachable compartments can be defined as   ﬂ
#@	ﬀﬂﬁﬃ ﬀ! # " .
Definition 9 (Open). A compartmental system is called open if every compartment can
reach an exit.
The condition for openness can also be formulated as  %$'& ﬂ)(  +*"	 ﬂ  	 	 	! ( , where (
denotes the empty set.
Gershgorins theorem states that each eigenvalue of a matrix  lies in the union of the  disks
,.-
*  



,
	


A
 
A
	

,
 


A
,
. For the matrix  the centers of the disks are in ?    	  and the radius
is less than or equal to *H?    . Hence the real part for each eigenvalue
-
of  are non positive
( /D
-
0	  ) and no eigenvalue is purely imaginary.
In an open system with no external input (for    ) and with an initial amount of material
in each compartment, the equation for the change of material is
 !#" $'&
 ($
ﬂ ,  . Clearly
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  k(1,3) 
  k(1,2) 
  k(3,2) 
  k(2,1) 
  k(0,3) 
  U(1) 
Figure 2.2: An example of a compartmental model with a circuit of length 3. The indices
in the circuit are 3,1,2.
    as   , and the system cannot have a constant particular solution i.e. no eigen-
value of  is 0. Hence /D
-

 
 for every eigenvalue
-
, and therefore  is nonsingular.
A circuit of a graph is a set of distinct indices #    	 	 	 # such that ? A  A	! 	 	 	0 ?-A	



A	
  ?-A	


A ﬂ  ,
as in the example in figure 2.2. If
-
is an eigenvalue of  then
-
9  is an eigenvalue of

ﬂ  9  , also if  is irreducible then  is irreducible. Theorem 1 in [7] states that if 
is irreducible and non-negative and the longest circuit in the graph of  has length 2, then
all eigenvalues of  are real.
If ) ﬀ is chosen such that  ﬂ  9    ,  is irreducible and the longest circuit of 
are of length 2 then all eigenvalues of  are real.
2.2 Tracer/tracee experiments
Consider an experiment to study the amount of lipoproteins secreted from the liver per hour.
If the lipoproteins are characterised by their density, a particle newly secreted from the liver
cannot be distinguished from a particle that have circulated the system for a while. Therefore
it is impossible to describe the kinetics of the particles. This is a case where tracer/tracee
experiments are useful. By introducing markers or labels on some of the particles secreted
from the liver, these can be followed by measuring the concentration of labelled particles.
The labelled material is called the tracer and the material being studied is called the tracee.
Knowledge about the kinetics of the tracee can be gained by studying the kinetics of the
tracer.
When choosing the tracer one must consider several aspects, the most important are
i) The biological system should not be able to distinguish between the tracee and the
tracer.
ii) In steady-state experiments, the amount of tracer should be small enough not to affect
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the steady-state.
iii) If the tracer is an isotope, there should be no exchange of isotope between labelled com-
pounds and other compounds, and the natural occurrence of the isotope should be neg-
ligible or at least under control.
Let  be the mass of the tracee and   the mass of the tracer. The system for the total mass is
)
  9  
)

ﬂ   9  
    9   9 + 90
 
where 0 is the input of tracer. Or, for a single compartment
)
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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 	
If the mass of the tracer is assumed to be small compared to the tracee mass, the right hand
side can be Taylor expanded in 

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Subtracting (2.2)
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If the amount of tracer is small, the quadratic term can be neglected, and the resulting system
is linear in  
)
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
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In the linear case, the equations are
)
  9  
)

ﬂ     9   9 + 9 
 
subtracting (2.3)
)
  
)

ﬂ  	   9  	 (2.6)
2.3 Sampling
In experiments the outputs are sampled. Let  be the number of outputs and 
  the number
of time points when the 	 :th output is sampled, and    A the # :th time point, #4ﬂ  	 	 	- 
 
and 	Dﬂ  	 	 	! ( . The outputs are usually ordered so that the tracee outputs are  	 	 	! (
and the tracer outputs   9  	 	 	- ( . The samples are denoted    A and if    A is a sample
of 




A- we write 


A 




A! . Here 


A 




A- ﬂ  


 


A! for 	 ﬂ  	 	 	! ( and



A  




A Lﬂ
" $
 ﬀ
&


!#"%$


A
&
for 	ﬂ)  9  	 	 	! ( .
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2.4 Modelling delays
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Figure 2.3: Delay as a compartmental system. The symbol for compartment 6 will be used
for delays.
Reactions may not be instant, and therefore delays must be considered. There are several
ways of implementing delays, here the method used by the SAAMII program (Section 2.8) is
described. Consider an in-signal as in figure 2.4(a). A mathematical delay will, as shown in
figure 2.4(b) give a time shift of the input function. But a more physiological delay might be
a more blurred or diffuse delay, as in figure 2.4(c) and 2.4(d). The delay can be modelled as
a number of compartments   with the same transfer-coefficients ? .  is defined to be the
time it takes for the first compartment after the delay to reach its maximum amount given
an instant input to the delay. The equations are
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or
)
 
)

ﬂ ,  9+ 	 (2.7)
To decide how to choose ? , fix  and use a instant input
 ﬂ 
0 ﬂ   



 (2.8)
The solution to (2.7) - (2.8) is
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Note that  ﬂ *H?  9ﬃ?   , where  has ones on the first sub-diagonal. Clearly   ﬂ   ,
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This gives an equation for the mass in the 	 :th compartment
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The maximum is attained when
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(b) time shifted signal
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(c) delay-time   h
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(d) delay-time  h
Figure 2.4: Delays modelled as in figure 2.3 for    and ﬀ  . Input signal is a
constant function. 5 compartments - ’ ﬁ ’, 10 compartments - ’ ﬂ ’ and 15 compartments - ’ ﬃ ’.
Notice that the sharpness of the delay depends on the number of compartments and the
desired delay-time.
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So compartment 	 in the delay attains its maximum at  ﬂ 	L* ! ?  , hence the first com-
partment after the delay attains its maximum at  ﬂﬁ ?  . Therefore choose ?;ﬂﬁ ! .
2.5 Linear ODE
The systems that arise are of the form

  ﬂ    9 +
 
    ﬂ 0 	
There is a very large literature on ODE-systems, and here only give a short introduction to
linear equations is given. Consider a constant coefficient problem

  ﬂ    9 +
 (2.9)
    ﬂ   	 (2.10)
The homogeneous system
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a (square) matrix  ,   is defined as
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A particular solution to (2.9)-(2.10) is given by
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The input function + is often constant for the tracee and the tracer (in many cases the
tracer is an instant injection and therefore   ﬂ  ). In these cases the solution is (if K is
nonsingular)
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A solution to the linear model, equation (2.6) with 0 ﬂ  can be written as
   ﬂ 
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
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 
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
 	
Where   are constants,
-
 are eigenvalues of  and

 the corresponding eigenvector. If the
eigenvalues have negative real part, then the solution will be damped and go to 0 as  goes
to grows. If the eigenvalues are real, then there cannot be any oscillations.
2.6 Optimisation - fitting curves
As for ODE’s, there is an extensive literature on optimisation and the aim of this thesis is not
to fully cover these theories.
2.6. OPTIMISATION - FITTING CURVES 15
In a general ODE model there are measurements    of a known function 4 at time points
 ﬂ   ,
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where  is the set of unknown parameters.
Note.  can depend on  since an unknown proportion of compartments might be measured. Initial
amounts can be treated as instant injections and     ﬂ  .
The problem is to find
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subject to   , where 4 ﬂ4   and ﬂ- 

 /  

 is a measure of the error be-
tween the calculated and measured value at the 	 :th time point. In the linear tracer/tracee
compartmental case the samples are as in Section 2.3. The objective function is defined as
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The minimising problem is,
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Note.    is usually known, but it might be the case that one injection goes into more than one
compartment and in an unknown proportion.
How should the error function ﬂ-ﬀ  ﬀ  be chosen?
2.6.1 Least squares
A possible approach could be to define ﬂ-

ﬀ
 
ﬀ
 ﬂ


,

ﬁ

*
ﬁ

,
i.e. the distance between the
components in ﬀ and ﬀ , and the total distance between the measured and calculated values
are minimised. But this function has some drawbacks; it is not differentiable and the penalty
for large errors is too small. For example; every point between two points (say 0 and 10)
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have the same total distance to them. Given three points 0, 0 and 10, the point 0 has the
smallest total distance to the three points. Clearly the distance is not a good error function.
The function ﬂ! ﬀ  ﬀ Fﬂ 



ﬁ
 *
ﬁ
 
 is differentiable and have a quadratic penalty. This
gives the least squares estimation and is the most common curve fitting method. In the
two examples above, the points 5 and 3.333 are the best approximations. The least squares
objective function is
 
L ﬂ
ﬂ

   



A  
  
 AF*      
 A-

	
Assume that 4   and +   are the correct model. Then there exists an parameter vector

 such that
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 A ﬂ   

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 
 A-
 
and hence
 


 >ﬂ   
where

 solves

 >ﬂ 4

    9 +

0  	
Least squares is a very common technique in parameter estimation, numerical analysis and
optimisation. The reasoning above is an attempt to explain least squares to non-mathemati-
cians. There are a great literature in least squares and it can be found in almost any book
in numerical analysis, statistics, optimisation etc. For the implementation used here, books
like [5] and [12] on Regression Analysis or [4] on nonlinear parameter estimation are recom-
mended for further reading.
A more mathematical justification for least squares is that if the errors are independent and
identically distributed        the least squares estimate coincides with the maximum like-
lihood estimate.
An objective function with a simple sum of squares is often unsatisfactory. The size of the
measurements may vary, here the tracee/tracer ratios are of order  

 and pool sizes are
up to    , or some measurements are less reliable than others. The solution to these two
drawbacks to introduce weighted least squares. The weighted least squares is here defined
as

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 (2.11)
for    A   .
In every experiment there are errors     A in the measurements, so
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Assume that &      A- ﬂ  and that the variance of the error element     A is    A . There are
several ways to deal with errors in the measurements. For instance one can give a weight
to each term in the objective function according to the variance of the measurement. Let
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A
in 2.11.
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If a point is measured with high accuracy, i.e. its variance is small, that data point will have
a large weight in the objective function. An other common way of weight data is to weight
each sample by    

 A
(or        A!  ), which gives a penalty in terms of relative error rather
than absolute error.
It can be assumed that the variance can written as
 
    
 A- ﬂ
 

 AI  
 A@      
 A 
 A  	
i.e. the variance depends on the sampled value    A , the calculated value    A and a parameter
1A . 1A is a measure of how good the data set # are and may depend on the accuracy of the
different methods used in the experiment. It is often assumed that the variance depends on
"
 A or   A , depending on weather it is believed that the model or data is more correct.  A
may depend on the method used for analysing the data.
As discussed in Section 2.8, in the software used to interpret the model the objective function
also includes a logarithmic term of the weights. It is also possible to include a Baysian term
in the objective function. There may exist some a priori information for some parameters.
This may come from population average or from earlier experiment.
2.6.2 Search algorithms
After choosing a starting point   there are several approaches to find an optimal solution. In
general, most search algorithms are based on the following; First a search direction is chosen,
and then a step length. This is repeated until an optimum is reached. The most common are
the steepest descent search direction; it finds the direction in which the greatest change of the
objective function is achieved.
2.7 A four compartments example
Here is a simple example of a compartmental model. It is also the first attempt to model
lipoprotein kinetics. The tracee in this model is the apoB, or even more specifically - the
leucine amino acids in the apoB molecules. How the labelling is done and why leucine is
chosen as the tracee is described in Section 3.1. The tracer is a stable isotope of leucine. Let K  
be the mass of free leucine in the blood and in the liver, let further K

, K

and K be the mass
of leucine in VLDL, IDL and LDL respectively. Denote the corresponding tracer masses by


 	 ﬂ        . With external input of tracee from the environment and an instant injection
of tracer into compartment 1. The compartmental system is shown in figure 2.5, and the
equations describing the model are
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where   is the injected mass. And
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Consider a steady state experiment with two measurements of total apoB in VLDL, IDL and
LDL at 0 and 8 hours and 9 measurements of enrichment of free leucine, leucine in VLDL
apoB and leucine in IDL and LDL apoB together (every hour). The outputs are defined as in
figure 2.6 and 2.7, and the sampling matrices are
. ﬂ
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   
   
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For the tracee, the measurements s1, s2 and s3 (see figure 2.6) are denoted

- AI F# ﬂ  
(0 and 8 hours) and corresponds to .0  . Similarly there are measurements s4, s5 and s6,
for enrichment (see figure 2.7). The measurements are denoted  A where # ﬂ  	 	 	-  . For the
tracer,  corresponds to

"%$'&

!#"%$'&
(where the division is element by element). The least squares
4
LDL
3
IDL
2
VLDL
1
LIVER
  k(4,3)   k(3,2)   k(2,1) 
  k(0,4)   k(0,3)   k(0,2)   k(0,1) 
  U(1) 
Figure 2.5: Compartmental model of the system.
Q1
LIVER
Q2
VLDL
Q3
IDL
Q4
LDL
  k(2,1) 
  k(3,2) 
  k(4,3) 
  k(0,1) 
  k(0,2) 
  k(0,3) 
  k(0,4) 
  U(1) 
s3s2s1
Figure 2.6: Tracee samples of VLDL, IDL and LDL at 0 and 8 hours.
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q1
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IDL
q4
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  k(2,1) 
  k(3,2) 
  k(4,3) 
  k(0,1) 
  k(0,2) 
  k(0,3) 
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ex1
Figure 2.7: Enrichment of free tracer, tracer in VLDL and in IDL and LDL together.
objective function is
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In this case  
 
ﬂ   


ﬂ  and  
A
ﬂ # *  L# ﬂ  	 	 	-  . A solution to this (minimising the
errors as described in Section 2.6) may look as shown in figure 2.8.
0 1 2 3 4 5 6 7 8 hour
leucine (apoB)
VLDL   Q2
LDL  Q4
IDL  Q3
(a)
0 1 2 3 4 5 6 7 8 hour
enrichment of labelled leucine
plasma
VLDL
IDL+LDL
(b)
Figure 2.8: Possible solutions to the system, solid lines refer to calculated solutions and
dashed lines to measured values. The error is the sum of squared differences between
calculated and measured values.
2.8 Modelling software - The SAAMII program
In this thesis a commercially available program called SAAMII (Simulation, Analysis And
Modelling) is used to create the model and perform the optimisation. SAAMII consist of a
numerical and a compartmental module. The compartmental module has been used for the
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modelling. A system is easily created by drawing compartments on the screen and transfer
rates are assign by linking compartments together.
In SAAMII tracer/tracee experiment is then created by making a system (tracee) and a tracer
experiment. The outputs are created as samples of the compartments and are associated
with user data. Delays are modelled as a single component and implemented as described
in Section 2.4.
2.8.1 Optimising in SAAMII
In SAAMII the objective function is a weighted least squares function with the variance as
weights. The variance model is
 
   
 A! ﬂ
 

 AI    
 AI      
 A 
ﬂ  .
 A 	
Where   is a measure of the set variance i.e how good the data set are. The objective function
also includes a logarithmic term of the weights. Without such a term, the objective function
could be arbitrary decreased by choosing parameters that increase the estimated variance.
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Where   is the total number of time points. There is also a possibility to use Baysian esti-
mation of one or more parameters. If where are some parameters with a known mean and
standard deviation (from earlier studies or population means) these parameters are being
treated as an extra data set. The extra term in the objective function is
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where   are the parameters,   their mean values and   the standard deviation. 
  is the
number of parameters being estimated with Baysian estimation.
2.8.2 Variance and weights
Variance model based on data based on model
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Table 2.1: Variance models used by SAAMII, ﬁﬀﬂﬃ "!#"$%'& are user supplied.
For the variance model, the eight combinations in table 2.1 are possible. The   component
is estimated by
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For more information about SAAMII, visit www.saam.com or read [17].
Chapter 3
Lipoprotein experiment
This is a mathematical thesis, focusing on the mathematical model of lipoprotein metabolism.
All clinical measurements and the analysis of blood samples are done by researchers and
technichicans. The recruited subjects were all finish people. The samples were taken at the
University Hospital in Helsinki, Finland, by Professor Marja-Riitta Taskinen and staff. All
the analyses except for enrichments were done in Helsinki. The analysis for tracee/tracer ra-
tios were carried out in The Royal Infirmary, Glasgow, UK, by Dr Muriel Caslake and staff.
A short description of how the analyses were done is presented here.
3.1 Labelling of particles
In the studies, both the flow of particles and the flow of triglycerides were measured. There-
fore the lipoproteins and the TG must be labelled individually. The particles were labelled
by a bolus injection of labelled leucine (L-leucine-d

, 7 mg/kg). The labelled leucine is,
in the liver, used as material for apoB (the apoB molecule consists of 12.12  leucine, i.e.
about 550 amino acids of leucine). The TG was labelled by a bolus injection of labelled glyc-
erol (D-5-glycerol, 500 mg). In the liver, the labelled glycerol is inserted into the TG. Both
L-leucine-d

and D-5-glycerol are stable isotopes.
3.2 Data
For each subject in the study the pool-sizes (total amount in plasma) of apoB and TG, were
measured at 0, 4 and 8 hours in VLDL   and VLDL  . From that the leucine in apoB and
glycerol in TG were calculated. Moreover, the enrichments of labelled leucine and glyc-
erol were measured at 0, 15, 30, 45, 60, 75, 90, 120, 150, 180, 240, 300, 360, 420 and 480
minutes in VLDL   and VLDL  . Additionally measurements of enrichment of free leucine
in plasma were done at 2, 6, 8, 10, 12, 15, 20, 30, 45, 60, 120, 180, 240 and 360 minutes. Let
3

A
 	ﬂ      ﬂ be the time points for measurements of pool sizes in leucine VLDL   , leucine
VLDL  , glycerol VLDL   and glycerol VLDL  ( 
  ﬂ    L	 ﬂ      ﬂ ) and let    A L	 ﬂ        
be the time points for measurement of enrichments of leucine VLDL
 
, leucine VLDL

, glyc-
erol VLDL   and glycerol VLDL  ( 
  ﬂ    	ﬂ         ).
Finally let    A be the time points for enrichment of leucine in free plasma ( 
  ﬂ  ). This def-
inition gives the possibility to exclude samples if some errors occurred during the analysis
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of the plasma or in the experiment.
Name time points
  
 A   
 A # ﬂ  	 	 	- 
  
total leucine in apoB VLDL
 
mass
 
 A  
 A # ﬂ  	 	 	- 
  total leucine in apoB VLDL  mass


 A 

 A # ﬂ  	 	 	- 


enrichment of labelled leucine in apoB VLDL  
 
 A  
 A # ﬂ  	 	 	- 
  enrichment of labelled leucine in apoB VLDL 
    A     A # ﬂ  	 	 	- 
   enrichment of labelled leucine in free leucine


 A 

 A # ﬂ  	 	 	- 

 total glycerol in TG VLDL
 
mass
  A   A # ﬂ  	 	 	- 
 total glycerol in TG VLDL  mass
  A   A # ﬂ  	 	 	- 
	 enrichment of labelled glycerol in TG VLDL  

 
 A 
 
 A # ﬂ  	 	 	- 

  enrichment of labelled glycerol in TG VLDL 
Table 3.1: Data sets.
3.3 Separation of densities and analysis of leucine and glycerol
The VLDL   and VLDL  were separated from plasma by cumulative flotation gradient ultra
centrifugation. This method is described in [8], and only a brief description is given here.
To the each sample (8.4 mL) 0.6 mL of NaCl (density ) ﬂ 	ﬁ
  g/mL) was added and the
samples were put in a centrifuge. Particles with density greater than ) ﬂ 	ﬁ
  g/mL float up
during the centrifugation and can then be separated from the plasma. A similar procedure
was then applied to further separate the VLDL   and VLDL  particles.
To determine enrichment of labelled leucine, apoB molecules were separated (as described in
[8]) and enrichment measured with gas chromatograph mass spectrometry. The method for
measure enrichments of labelled leucine generally generates good data, whereas the method
for labelled glycerol gives more noise and more spikes in the data.
3.4 Subjects
For the development of the model, 12 healthy subjects, nine normolipidemic and three with
impaired glucose intolerance (IGT) was recruited. For the design of the model the nine
normals was used. The subjects (the nine normolipidemic and one IGT, see Section 5) are
further characterised in appendix A. The enrichments of apoB and TG are presented in
figures A.1-A.10.
Chapter 4
Mathematical models
The apoB model was first developed, as it serves as a base for the glycerol model. As particles
always are losing lipids their density is increasing monotonically. This gives a lower trian-
gular system for the apoB and glycerol lipoprotein system. The model used for VLDL   and
VLDL  apoB was first developed by C. J. Packard et al. [10]. The output compartments and
corresponding functions are defined as in Section 2.3 and table 3.1.
4.1 apoB
A simple apoB model is described in Section 2.7. Now the model for the assembly of apoB
molecules as well as the apoB VLDL
 
and VLDL

kinetics are described.
4.1.1 Liver-plasma leucine
The following model (figure 4.1) for liver-plasma apoB synthesis is described in [9]. The
labelled leucine is injected into the plasma-leucine compartment (comp. 1), which is con-
nected to a intracellular compartment (comp. 2). The fractional transfer coefficients between
compartments 1 and 2 are equal, which gives an equilibrium between compartments 1 an 2.
The intracellular compartment is the source for apoB synthesis. Compartments 3 and 4 are
body protein pools accounting for uptake and slow release of leucine. Compartment 11 is
the delay compartment (7 compartments for the delay is used, see Section 2.4). The sampled
output is compartment 1, and   @ is defined as
   ﬂ

 !   
K
 

	
The unknown proportion of plasma leucine that actually is in the plasma (not in liver etc) is
denoted    .
4.1.2 VLDL
 
As described in Section 1.2, newly secreted particles in the VLDL
 
density are very TG-rich
and undergo hydrolysis as the apoC activates the LPL. In the next step particles are either
converted to VLDL

particles or removed by catabolism. In this model the particles enter
the VLDL   fraction at one compartment. The model also allows for particles to be removed
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from the hydrolysis-chain. Figure 4.2 shows the corresponding compartmental system. The
VLDL   data described in Section 3.2 correspond to K   9 K  9 K  (the tracee mass) and









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

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Figure 4.1: Liver-plasma. Compartment 1 is the plasma-leucine compartment where the
leucine is injected. Compartment 2 is an intracellular compartment which is the source for
apoB synthesis. Compartments 3 and 4 are body protein pools. The output is at compart-
ment 1.
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Compartments 5 and 6 are the delipidation chain and compartment 7 is the remnants com-
partment which allows for a slowly decaying component. There is a possibility for particles
to be consumed by direct catabolism through compartment 6. The fractional transfer coeffi-
cient ?    is initially set to 0. The fractional transfer coefficients in the delipidation chain are
set to be equal, i.e. ?     ﬂJ?    .
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Figure 4.2: VLDL  . Compartments 5 and 6 are the delipidation chain and compart-
ment 7 is the remnants compartment which allow for a slowly decaying component. The
VLDL  output is the sum of compartments 5, 6 and 7.
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4.1.3 VLDL

The VLDL

particles are described by a system similar to that of VLDL
 
. For the normolipi-
demic subjects it was not necessary to use two distinct pathways. Particles coming from
the liver can either be converted to IDL (through compartment 10) by further hydrolysis or
they can be removed by catabolism (via the remnants compartment 9). In the model used
here, particles coming from VLDL   can be removed by the same mechanism as newly se-
creted particles using compartment 9 in figure 4.3. Note that it is impossible to distinguish
between catabolism and transfer to IDL from compartment 10, therefore ?      is set to the
sum of the transfer to IDL and the direct catabolism. Let ?     ﬂ=?      9ﬁ     , where ﬁ     ,
the direct catabolism from compartment 10, is initially set to 0. Another possibility would
be as in figure 4.4 where newly secreted particles are either cleared using compartment 13
or further hydrolysed with particles coming from VLDL
 
. Using the model in figure 4.3 the
VLDL  outputs are the sums of compartments 8, 9 and 10, giving the following functions
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Figure 4.3: VLDL  . The VLDL  system is similar to the VLDL  system. Compartments
8 and 10 are the delipidation chain and compartment 9 the remnants. The outputs of the
VLDL  are the sums of compartments 8, 9 and 10.
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Figure 4.4: VLDL  . An alternative, but not yet tested, system there compartments 8
and 10 are the delipidation chain. Particles coming direct from the liver (via comp. 12)
may be transferred into the delipidation chain or become remnants (comp. 13). Here the
VLDL  output would be the sum of compartments 8, 10, 12 and 13.
4.2 TG
The triglyceride model inherits most of the structure from the apoB model described above.
4.2.1 Liver-plasma
In the early paper by Loren A. Zech et al. [16] they presented a model for TG kinetic within
the VLDL subclass. The model had a 5 compartment subsystem for the VLDL kinetics and
4+1 for the liver glycerol/TG conversion. Here a modified version of the liver model was
used. Compartment 13 is the plasma-glycerol compartment where the glycerol is injected,
and compartment 12 is a glycerol pool. Compartment 14 is the glycerol-TG conversion there
compartment 21 is the slowly decaying compartment. The delay (comp. 22) is a 5 compart-
ment delay initially set to 0.3 hours.
Other possible models could be to feed compartment 21 directly from compartment 12,
and/or to feed compartment 21 into 22.
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Figure 4.5: TG Liver system. Compartment 13 is the plasma-glycerol compartment and
compartment 12 a glycerol pool. Compartments 14 and 21 are the fast and slow compart-
ments respectively.
4.2.2 VLDL
 
and VLDL

The fractional transfer coefficients tells us the fraction of mass transferred per hour (or unit
time). From the apoB model, the fraction of particles transferred is known, but if say 10  of
the particles are transferred then 10  of the average TG mass is transferred as well. There-
fore, for VLDL   and VLDL  , the model for TG is almost the same as the model for apoB.
The two models have the same structure with the same fractional transfer coefficients be-
tween compartments, but in each step lipids are lost so an additional loss term from each
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compartment is added in the TG model. Compartments 16, 17, 18 and 20 have loss of TG
both from catabolism of particles and hydrolysis. The outputs for VLDL   and VLDL  are the
sums of compartments 15, 16 and 17 and 18, 19 and 20 respectively. The following functions
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Figure 4.6: TG VLDL  and VLDL  system. The system is very similar to the apoB sys-
tem. The outputs for VLDL  and VLDL  are the sums of compartments 15, 16 and 17 and
18, 19 and 20 respectively. Notice the loss (            	 ) of TG from all VLDL
compartments.
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are therefore sampled
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4.3 Reduction of parameters - finding dependencies
In this chapter the number of unknowns is reduced to a minimum. When referring to a pa-
rameters such as ?  

the numbering of compartments as in figures 4.1 and 4.5 is used. From
a computational point of view the number of unknown should be kept to a minimum in or-
der to get faster and more efficient algorithms. In physiological terms reducing parameters
is very critical, since by letting transfer-coefficients depend on each other the behavior of the
model is partially determined. In the apoB liver model it is assumed that; ?     ﬂ ?     and
?


Hﬂ ? 


	  . For the TG liver model the parameter values as in [16] is used. As mentioned
in Section 4.2.2 all fractional transfer coefficients between compartments are the same in the
apoB and TG model i.e. ? A   ﬂ ?!A

 




 
 for 5#@ 	3       I
 !  ﬂ   I
 -     I  !      
 !      .
There are also fractional losses of lipid ?  

for 	 ﬂ    	 	 	-  . These losses arise from direct
catabolism of particles and hydrolysis. Therefore, for example, ?     ﬂ ?    9 C  where C  is
the loss from hydrolysis. The ?    is bounded from below ?     ?   

 
 for 	0ﬂ    	 	 	-  (if
? 

A is not defined, ?   A is set to 0).
?
 


= ?


 
?


 = ?  

	 
? 

 

= 19 ?      

= 12 ?  


   = 5
?


 = ?     ?      = ?      9 ﬁ    
?
 


 
  = ?     ?
 


 
  = ?     ?
 


 
 = ?   
?



 
 = ?      ?         = ?    
? 

 
  = C   ?      = ?    9 C  ?      = ?    9 C 
? 

 
 = C  ?  
 
  = ?     9 C   ?  

 = ?  
 
 9
C
 

Table 4.1: Parameter dependencies and fixed parameters
4.4 Delays
When using the delay model described in Section 2.4, the resulting equation system is mod-
ified. Compartment 11 in figure 4.1 is an 
 
compartment delay, denote the compartments
in the delay by  

 
 	 	 	1  	


 (and ) 

 
 	 	 	1 
)



 ), and define the fractional transfer co-
efficient to be ? 


. Further, define B 



   

to be the fraction of apoB mass that goes to the
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which is an    by 4 matrix.
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is an    by    matrix. Moreover
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is a 6 by    matrix. Finally
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Note that 


plasma is the only matrix (on the diagonal of  ) that is not a lower triangu-
lar one. A model can be described with a lower triangular matrix if there is no feedback of
material. In this model this means that particles are always moving downwards i.e. increas-
ing their density.
4.5 The final model
The final apoB model is described in the Section above. The TG model is very similar. Com-
partment 22 in figure 4.5 is an 
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an   by 4 matrix.
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The relations between fractional transfer coefficients described in Section 3.2 imply that
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By the definition of the matrices 


and   

they are irreducible and their longest cir-
cuits are of length 2, moreover they are open and hence all their eigenvalues are real and
negative, according to Section 2.2. This means that there are no oscillations in solutions and
the solutions are damped as time goes to infinity. There are no constant term in the solutions,
and the tracer is completely washed out.
Chapter 5
Results
The subjects were chosen to have a wide spectrum of characteristics, in terms of bodyweight,
TG-levels and age. The goal was to design a model that is applicable to as broad range of
subject as possible. The nine normolipidemic and one of the IGT subjects were modelled.
The other two IGT subjects were not possible to model with the developed model. Data for
the ten subjects are presented in appendix A.
Each subject were modelled with the model described in Section 4 and the following quan-
tities were calculated: the fractional catabolic rate FCR, the fractional direct catabolic rate
FDCR, the direct production and the fractional transfer rate FTR. The formulas are presented
in appendix B and calculated values in tables 5.2 and 5.3, the fractional transfer coefficients
are presented in tables A.3 - A.6.
5.1 Optimisation
Due to the structure of the model the optimisation can be performed in a stepwise way. The
model as in Section 4 was implemented in SAAMII with the parameters dependencies as in
table 4.1 and 5.1. The data was weighted with relative weights, and was set to be 1  of the
data point for the enrichments, and 10  for the pools.
5.1.1 Plasma apoB
First the optimisation was performed over the parameters associated with the plasma, namely
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  . For most of the subjects ?   I and ﬁ     were zero.
Therefore ?   I and ﬁ 
 
 were initially set to 0. If necessary they were increased until a fit
was achieved. Once a fit was found, the plasma parameters mentioned in Section 5.1.1 were
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name interval description
  

  

Unknown proportion of K   measured
C


  

Loss due to hydrolysis from K   	ﬂ   	 	 	!  
B




   


  

Fraction of particles secreted as VLDL

particles
B
 



   


  

Fraction of TG secreted in the VLDL  subfraction
# 
   
	 


	   	

Delay time for the apoB
# 
   
	 



	  	 

Delay time for the TG
?   !

  ﬂ

Fraction catabolised from 1
?   I

   

Fraction catabolised from 6
?   ﬂ@

   

Fraction catabolised from 7
?   I

   

Fraction catabolised from 9
ﬁ    

   

Fraction catabolised from 10
?  I

   

Fraction transferred from 2 to 1
?   I

   

Fraction transferred from 3 to 1
?    !

   

Fraction transferred from 1 to 3
?    I

   

Fraction transferred from 3 to 4
?   I

   

Fraction transferred from 5 to 6
? ﬂ  I

   

Fraction transferred from 5 to 7
?   I

   

Fraction transferred from 8 to 9
?    I

   

Fraction transferred from 8 to 10
?  I

  	 

Fraction transferred from 2 to 11
?     I

  	

Fraction transferred from 13 to 14
?   !

   

Fraction transferred from 21 to 14
?   

   

Fraction transferred from 14 to 21
?    

  

Fraction transferred from 14 to 22
  
 ﬂ!




 ﬁ  


  

Amount of free glycerol in plasma
  
 ﬂ!

 ﬁ
	


  

Amount of free leucine in plasma
Table 5.1: Adjustable parameters. 
	 will be the mass in compartment 1, and
	ﬀﬁﬂﬃ!  the mass in compartment 13. Other parameters are as in table 4.1.
made adjustable and the optimisation was repeated - but little or no improvement of the fit
was achieved.
5.1.3 TG
After achieving an optimum for the apoB model, the next step is to optimise over the TG
model. All apoB parameters are fixed and the adjustable parameters are C   	 ﬂ   	 	 	!   ,
?     I , ?   ! , ?    , ?     , B  



   

and # 
  	   . The objective is to fit 


to "  A at 3  A  	 ﬂ   	 	 	!   H#Jﬂ  	 	 	- 
  . In general the data for enrichment of labelled
glycerol were not as good as the data for labelled leucine.
5.1.4 Iterating
The TG model is based on the apoB model, which indicates that the apoB model should be
optimised first and then the TG model. The two reasons for this are;
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The apoB model has been tested in several studies, for instance [8], [10] and [9].
The techniques for the measurements of apoB are more accurate than those of TG, therefore
a better fit for the apoB model than for the TG model can be predicted.
Some difficulties occurred during the optimisation. The problem occurred when modelling
the TG, but the problem originated from the apoB solution. The two most common problems
were
1. Delay time. The delay time for the apoB was in some subjects slightly large, due to a
large weight of the first measurements of the enrichment. In the model this results in a
high production rate, and therefore a large FCR. A lower weight for the first measure-
ment gave a shorter delay time and produced a better fit.
2. ?   I . As mentioned earlier, the direct catabolism from compartment 6 was initially
set to 0. If no feasible fit was achieved it was allowed to vary. This often resulted in
a very large ?   I . Therefore ?   I was defined to be the least ?   I to produce a
feasible fit.
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VLDL   VLDL 
subject FCR FDCR FTR Prod FCR Prod Dprod Tprod B  



   

dT
1 26,69 22,21 4,48 39452 17,12 9256 2631 42084 0,94 0,32
2 24,15 22,45 1,70 29620 13,51 5338 3251 32872 0,90 0,40
3 17,09 13,73 3,36 12108 8,98 3292 913 13021 0,93 0,32
4 8,04 6,39 1,65 11668 5,00 4119 1721 13389 0,87 0,29
5 16,85 16,20 0,66 55763 9,62 10074 7899 63662 0,88 0,21
6 37,56 30,78 6,78 19486 13,69 5283 1764 21250 0,92 0,33
7 32,84 22,69 10,15 31969 32,21 14077 4192 36162 0,88 0,28
8 54,24 45,97 8,27 40156 35,50 7685 1563 41719 0,96 0,20
9 13,12 11,06 2,06 29956 9,07 6585 1879 31835 0,94 0,40
10 15,20 11,57 3,63 22461 10,58 6962 1596 24056 0,93 0,23
mean 24,58 20,30 4,27 29264 15,53 7267 2741 32005 0,92 0,30
stderr 13,15 10,94 2,99 12955 9,70 3038 1943 14498 0,03 0,07
Table 5.2: Calculated TG values for subjects. Prod, production; Dprod, direct production; Tprod,
total production; dT,  ﬃ  ﬂ 	   . FCR, FDCR and FTR [pools/day]; Prod, Dprod, Tprod [mg].
VLDL   VLDL 
subject FCR FDCR FTR Prod FCR Prod Dprod Tprod B 



   

dT
1 15,15 6,72 8,43 889 6,71 619 124 1013 0,88 0,46
2 16,53 11,75 4,78 799 5,98 409 178 977 0,82 0,48
3 12,74 8,22 4,53 383 3,53 231 95 478 0,80 0,73
4 6,22 3,23 2,98 275 2,13 219 87 363 0,76 0,45
5 5,93 3,29 2,64 840 4,19 655 281 1121 0,75 0,47
6 31,50 23,82 7,68 1078 6,29 523 260 1338 0,81 0,51
7 14,53 5,97 8,56 580 6,68 494 152 733 0,79 0,48
8 28,33 7,17 21,16 683 10,42 762 252 934 0,73 0,54
9 8,10 1,76 6,34 628 6,28 631 139 767 0,82 0,48
10 9,42 0,00 9,42 695 5,43 855 160 855 0,81 0,58
mean 14,85 7,19 7,65 685 5,76 540 173 858 0,80 0,52
stderr 8,79 6,77 5,31 237 2,23 209 69 290 0,04 0,08
Table 5.3: Calculated apoB values for subjects. Prod, production; Dprod, direct production; Tprod,
total production; dT,  ﬃ  ﬂ 	  . FCR, FDCR and FTR [pools/day]; Prod, Dprod, Tprod [mg].
Chapter 6
Discussion
6.1 Expected Values
There are many biological as well as mathematical considerations to be made when propos-
ing a model. Though it is not a guarantee for the model to be correct, it is advisable to start
by considering whether the results are physiologically possible.
Rough bounds for some quantities can be calculated and be compared to other studies.
VLDL   are richer in TG than VLDL  so clearly the fraction of TG going to VLDL   ( B  



   

)
should be greater than the fraction of apoB ( B 



   

), equality should hold if and only if both
are 1 or 0.
There are many studies on apoB metabolism. In for instance [8], [9] and [13] values of
 * ﬃ of apoB to VLDL
 
are normal, and ﬂ  * ﬃ are most common. There are not
many studies done on VLDL   and VLDL  TG metabolism, but some rough calculations can
be made. Since the model only includes apoB and TG, only the ratio TG:apoB (see subject
data in appendix A) can be considered. Newly produced particles are rich in TG and hence
their TG:apoB ratio should be greater then the average ratio of the pools. Now apparently
in table A.7 the TG:apoB ratio for newly secreted VLDL
 particles are greater than the av-
erage VLDL   ratio for some subjects. This is probably because new VLDL  particles has
low apoE and apoC as well as cholesterol content and their TG content may therefore vary
within a certain density interval. The cholesterol is transferred from HDL to apoB-containing
lipoproteins by cholesterol ester transfer protein, CETP, [15].
6.2 Delay times
There is a big difference in delay times between apoB and TG. For apoB the delay time is
	  	ﬁﬃﬂ hours (31 minutes), whereas for TG it is 	   	ﬁ hours (18 minutes). This
indicates that the TG is added late in the synthesis of the lipoprotein.
6.3 VLDL

and VLDL

sizes
The newly secreted VLDL   particles are 2 times as rich in TG as the average VLDL   particle
(43 to 25), but the newly secreted VLDL

particles have 3 times as much TG then the average
VLDL  particle (16 to   ﬂ ).  of the TG is secreted into the VLDL   subfraction. These
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facts indicates that most of the VLDL particles secreted from the liver have high TG to apoB
content - VLDL  particles are secreted in the lower density region of the VLDL  subfraction.
6.4 Numerical results
The plasma was successfully fitted in all subjects except for subject 8. Subject 8 had a hump
in the data between 1 and 3 hours, these points were excluded during the optimisation. The
results for subject 8 might not be relevant, in table A.2 the TG to apoB ratio in VLDL   is
above 40 at 0 hours, and is very high at 4 and 8 as well. The TG to apoB ratio in VLDL

is
very low. This indicates that subject 8 might not by a normolipidemic.
Good fits for the apoB model were achieved for all the subjects. The apoB model was also
successfully applied to a total of 21 subjects (not presented here). The solutions are presented
as solid lines in figures A.1-A.10, in appendix A.
In subjects 2, 5 and 9 there is a ’hump’ in the apoB, VLDL

data at approximately 1 hour.
Since the solutions are sums of exponentials it is impossible to achieve such a hump in the
solution. For subject 6 the data point at 6 hours for VLDL  is almost 0, and was left out
during the optimisation. In some subjects, at some time points, the VLDL   and VLDL  were
either slightly to close (as in subject 2 at 5 hours) or to much apart. This may indicate that
there has been a problem with the separation of VLDL
 
and VLDL

. Such time points
have been left out during the optimisation. Another possibility would be to fit the total
enrichment of VLDL   and VLDL  to the weighted sum of the data points, where the weights
are the average pool sizes.
For the TG the data is not as good as for the apoB. For VLDL   the data are fairly good, but
for VLDL  there is some noise. In for instance the subject 4 and 5 the VLDL  data are very
noisy.
Chapter 7
Further development
7.1 The present model
There are two main improvements to be made to the present model. First, the time inde-
pendent model will be further developed to be applicable to subjects with IGT and type-2
diabetes as well. When the current model was applied to IGT subjects it turned out that
the enrichment of TG in VLDL

was not always possible to model. The enrichment for
VLDL  grows for a longer period of time - and hence the peak for VLDL  comes later than
for the normolipidemic subjects. This phenomenon is probably more noticeable in the type-2
diabetes subjects. The inflow of particles to VLDL  comes both from VLDL   and from the
liver. In the current model VLDL  particles are supposed to have the same kinetics, inde-
pendent of their origin. If the pathways for these particles were separated, the liver would
produce a fast growing and decaying curve for VLDL  . VLDL  from VLDL   would be a
more slowly growing curve, since it is fed from VLDL
 
.
The next step will be to make a time dependent model, to study the effect of insulin on apoB
and TG secretion. Insulin is known to lower TG levels. Insulin regulates the availability of
free fatty acids (FFA) in the liver. In [8], a constant insulin injection was shown to lower the
apoB VLDL   production by ﬃ . Hence, VLDL   and VLDL  production can be regulated
independently. Insulin also alter the removal of lipoproteins by its effect on the LPL.
In the new model it will be possible to study not only how the secretion of particles are
affected by insulin but also how the composition is altered.
7.2 Other models
Apart from the improvements and modifications possible in the current model, e.g. the time
dependence in the insulin model, and the IGT/diabetes modifications, other mathematical
approaches to model are also possible.
In reality, there is a continuous distribution of particles with different densities, and the nat-
ural continuation of the project is to build a continuous simulation model. Such a model
could be done in a stochastic way, where each particle is modelled individually.
A continuous model will be more flexible and more easily allow to include new informa-
tion about the different metabolism at different densities. Apart from being useful in its own
right, such a model will make it possible to evaluate compartmental models under fully con-
trolled situations.
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The synthesis in the liver could also be modelled with this probabilistic approach. For in-
stance, the addition of triglycerides to the lipoprotein could be modelled in this way. A
model like this could give information about the density spectrum of particles secreted
from the liver. A question to adress is whether there are two distinct peaks for VLDL   and
VLDL

or is the spectrum smooth? With a statistical model, or any continuous model, it
would be possible to test the subdivision of VLDL to VLDL   and VLDL  . Is the metabolic
heterogeneity of particles in VLDL fixed or can it vary within the population or between
normolipidemic and IGT/type-2 diabetes subjects? The idea is to fit the model to the mea-
surements available but let the metabolic difference in VLDL be more or less independent of
the subdivision into VLDL
  and VLDL  .
If the difference of the real subdivision of VLDL and the subdivision VLDL   and VLDL  is
small, this could be tested in the compartmental model. For instance, the VLDL   data could
be fitted to K   9 K  9   * LK  9 K  and the VLDL  data fitted to LK  9   * K  9 K   9 K   
(the tracer/tracee ratios are defined in a similar way), where  2ﬂ     and    .
PSfrag replacements
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Figure 7.1: In a continuous model, the subdivision of VLDL into VLDL  and VLDL  could
be tested by fitting the model to the data available (VLDL  and VLDL  ), but the metabolic
difference is in the 	

and 

.
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7.3 Statistical problems related to compartmental modelling
There are several statistical problems related to tracer experiments and compartmental mod-
els.
In the model it is assumed that the labelled particles are uniformly distributed among all
the particles. Depending on how large proportion of particles that actually are labelled, the
distribution might not be uniform.
When normal, IGT and type-2 diabetes subjects are modelled it is possible to investigate
what differences and what similarities there are between these groups. For the insulin study
the same subjects are recruited, so there is a good statistical material to study the effect of
insulin.
The errors of the data has not been fully investigated. There are two ways of measuring
apoB mass, direct measurement or by measuring the total protein content and the mass of
non-apoB protein. Here the direct measurements of apoB has been used. Other possible ap-
proaches are to weight the apoB mass by the total protein mass divided by the sum of apoB
and non apoB proteins. This gives a ”recovery corrected” apoB mass.
The experiments are far from easy to carry out, and are affected by rather large errors. Many
enrichments are measured from the same blood sample, and therefore the errors cannot be
considered to be independent.
It might also be the case that is it possible to make assumptions on the errors and the vari-
ance of the data, depending on the different method used. But this is beyond the scope of
this thesis.
The stability of the model has not been investigated. The model should be tested for changes
in the data. The variance of both the output of the model, such as the FCR and production,
and estimated parameters should be investigated, also how sensitive the output is to changes
in the parameters.
Appendix A
Subject data
Subject age weight BMI BF Insulin TG chol HDL FFA-0 LF
1 64 90,0 27,2 29,5 7,79 1,57 4,49 0 714 0
2 53 90,5 27,9 26,8 7,00 1,02 4,40 1,25 413 0
3 56 80,3 27,8 24,2 2,80 1,22 4,68 1,51 530 5
4 47 75,2 26,3 24,2 4,79 2,23 7,51 1,54 588 1
5 55 84,0 16,5 24,3 6,00 1,98 4,60 0 357 0
6 59 92,3 30,1 27,5 7,00 1,19 5,32 1,56 549 3
7 45 69,8 24,1 17,2 3,25 1,86 6,36 1,19 598 2
8 49 71,5 24,0 20,3 6,41 1,44 5,66 0 606 0
9 57 95,9 25,9 28,1 9,00 1,24 4,01 0 461 0
10 52 71,9 24,0 19,5 8,00 2,00 5,30 0 542 2
mean 54 82,1 25,4 24,1 6,20 1,57 5,23 0,71 536 1,3
stderr 6 9,7 3,7 4,0 2,03 0,42 1,06 0,75 103 1,7
Table A.1: Subject characteristics, total number of subjects = 10. BMI, Body Mass Index
(       ) [kg/m  ]; BF, Body Fat 	
 ; LF, Liver Fat 	
 .
The enrichment of apoB and TG is presented as ’   ’ and ’  ’ respectively. The TG data are
scaled so that the maximum of apoB and TG VLDL
 
are the same. The solid lines are the
calculated enrichments.
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Figure A.1: Subject 1
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Figure A.2: Subject 2
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Figure A.3: Subject 3
0 1 2 3 4 5 6 7 8
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.1
Subject 4
Figure A.4: Subject 4
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Figure A.5: Subject 5
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Figure A.6: Subject 6
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Figure A.7: Subject 7
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Figure A.8: Subject 8
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Figure A.9: Subject 9
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Figure A.10: Subject 10
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VLDL
 
pool sizes
apoB TG TG:apoB
time 0 4 8 0 4 8 0 4 8
subject
1 63 56 59 1398 1422 1625 22,3 25,3 27,7
2 47 52 46 1135 1267 1273 24,2 24,3 27,7
3 25 31 36 607 746 826 23,9 24,3 23,3
4 47 43 44 1552 1388 1448 33,2 32,5 32,7
5 155 155 118 3513 3262 3145 22,6 21,0 26,6
6 39 34 29 1152 956 937 29,2 28,1 32,5
7 50 42 26 1242 908 783 24,6 21,7 29,7
8 14 23 25 617 730 740 42,9 31,4 30,1
9 81 82 70 2272 2502 2024 28,1 30,7 28,8
10 90 60 44 2176 1632 1131 24,3 27,1 25,6
mean 61 58 50 1566 1481 1393 28 27 28
stderr 40 38 28 880 817 740 6 4 3
VLDL

pool sizes
apoB TG TG:apoB
time 0 4 8 0 4 8 0 4 8
subject
1 99 91 78 594 520 499 6,0 5,7 6,4
2 66 68 71 381 405 399 5,8 6,0 5,6
3 79 59 59 405 338 360 5,1 5,7 6,1
4 90 121 110 726 893 844 8,1 7,4 7,7
5 116 168 178 930 1104 1104 8,0 6,6 6,2
6 83 87 79 374 407 368 4,5 4,7 4,6
7 89 75 59 489 387 426 5,5 5,2 7,3
8 71 65 85 202 232 211 2,8 3,6 2,5
9 96 112 94 707 649 773 7,4 5,8 8,3
10 154 151 154 694 673 594 4,5 4,4 3,9
mean 94 100 97 550 561 558 6 6 6
stderr 25 38 40 218 271 273 2 1 2
Table A.2: ApoB and TG pool sizes for VLDL  and VLDL  , [mg]
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subject ?   ! k   I ?   I ?    ! ?      ?  I Inj    plasma
1 3,24 4,50 5,90 1,21 1,00 0,0093 709 0,59 549
2 2,51 1,49 4,10 5,25 0,10 0,0096 715 0,63 517
3 2,59 6,58 0,42 3,18 0,02 0,0132 622 0,99 183
4 2,46 1,88 8,08 1,89 0,70 0,0066 588 1,00 280
5 3,32 3,35 9,22 2,49 0,59 0,0143 662 0,82 397
6 1,31 4,83 1,24 2,79 0,20 0,0094 729 0,45 718
7 3,61 3,69 3,05 2,44 0,52 0,0100 552 0,49 369
8 5,34 4,88 7,08 7,54 0,40 0,0167 566 0,55 283
9 0,07 2,54 0,03 2,66 0,02 0,0047 764 0,60 829
10 2,44 4,41 0,58 2,45 0,06 0,0114 567 0,44 379
mean 2,69 3,81 3,97 3,19 0,36 0,0105 647 0,65 450
stderr 1,40 1,55 3,43 1,85 0,34 0,0036 78 0,21 203
Table A.3: Plasma parameters for apoB; Inj, injected volume [mg];    , unknown proportion of com-
partment 1 sampled; plasma, 	    [mg].
subject       ?   I ?   ﬂ@ ?   I ?   I ? ﬂ  I ?   I ?    I
1 0,0000 0,8000 0,1931 0,2044 1,1060 0,0477 1,5367 1,1251
2 0,0000 0,0000 0,7688 0,3292 1,0968 2,6947 0,0000 0,4987
3 0,0078 2,3875 0,0059 0,0005 1,3255 0,0068 0,0008 0,5365
4 0,0000 0,9439 0,0144 0,0002 0,9294 0,0319 0,0004 0,3398
5 0,0000 0,5517 0,0003 0,0000 0,4434 0,0000 0,0000 0,3488
6 0,0000 1,3219 2,0000 0,0701 1,4357 1,6288 0,0294 0,6045
7 0,0000 0,0000 0,9290 0,3770 0,9745 0,6800 0,0365 0,5467
8 0,0000 0,0000 4,0000 0,5511 1,9058 0,6454 0,8738 0,6823
9 0,0003 0,0000 0,9670 1,1934 0,5717 0,1583 0,0000 0,5234
10 0,0000 0,0000 2,0000 0,5239 0,7848 0,0000 0,2993 0,2823
mean 0,0008 0,6005 1,0879 0,3250 1,0574 0,5894 0,2777 0,5488
stderr 0,0025 0,7942 1,2733 0,3717 0,4281 0,9036 0,5213 0,2383
Table A.4: Parameters for apoB model.
subject C   C  C  C  C   C
 

1 0,51 2,46 0,00 1,50 0,20 0,00
2 1,06 2,43 0,00 0,18 1,12 2,00
3 0,00 3,00 0,00 0,12 0,69 0,17
4 0,00 2,50 0,00 0,08 0,10 0,00
5 0,57 4,00 0,00 0,29 2,00 0,23
6 0,47 0,47 0,00 0,47 0,01 0,47
7 1,50 0,00 1,31 2,12 3,00 0,00
8 0,46 6,00 3,00 2,42 0,00 6,00
9 0,02 2,21 0,00 0,03 1,56 0,62
10 0,00 2,50 0,00 0,15 3,00 0,20
mean 0,46 2,56 0,43 0,74 1,17 0,97
stderr 0,50 1,67 0,99 0,92 1,18 1,87
Table A.5: Parameters for TG model.
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subject ?     I ?   ! ?    ?     plasma
1 0,1583 0,5057 0,5466 1,2442 1151
2 0,2000 1,0642 1,7584 1,6212 712
3 0,1132 0,2466 0,6671 1,1505 498
4 0,0886 0,2259 0,7277 1,4368 654
5 0,2409 0,2603 0,3489 0,6758 1145
6 0,0665 0,6773 1,5188 2,4472 1384
7 0,3160 0,1229 0,5347 0,7068 496
8 0,2000 0,2891 0,1395 1,1567 904
9 0,2000 1,4278 2,9692 3,8188 689
10 0,2027 0,0544 0,5751 0,7541 514
mean 0,1786 0,4874 0,9786 1,5012 815
stderr 0,0746 0,4461 0,8608 0,9697 316
Table A.6: TG liver parameters; plasma, 	ﬁﬂ !  [mg].
TG:apoB VLDL   TG:apoB VLDL  VLDL   : VLDL 
subject Prod Pool Prod Pool Prod Pool
1 44 25 21 5,9 2,1 4,3
2 37 25 18 5,8 2,0 4,4
3 32 24 10 5,6 3,3 4,2
4 42 33 20 8,0 2,2 4,1
5 66 23 28 6,7 2,4 3,5
6 18 15 7 4,6 2,7 3,3
7 55 24 28 5,9 2,0 4,1
8 59 31 6 3,0 9,5 10,4
9 48 29 14 7,2 3,5 4,1
10 32 20 10 4,2 3,2 4,8
mean 43 25 16 5,7 3,3 4,7
stderr 14 5 8 1,5 2,3 2,0
Table A.7: TG to apoB ratios for VLDL  and VLDL  . Prod, ratio in newly secreted particles; Pool,
ratio in the pools, compare with table A.2.
Appendix B
Calculated values, formulas
The following quantities was calculated for all subjects. (The factor 0.1212 in apoB is the
conversion from leucine mass to apoB mass. The factor    comes from that the TG have
a molecular weight of 882 and glycerol have a molecular weight of 92.)
Fractional Catabolic Rate, FCR The total loss from each fraction in pools/day.
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Fractional Direct Catabolic Rate, FDCR The loss due to direct catabolism from each frac-
tion in pools/day. (Same as the  .	  for VLDL

)
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Fractional Transfer Rate, FTR The transfer rate from VLDL
 
to VLDL

in pools/day. (Same
as  . =* 
.	  )
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Direct production The direct production from the liver.
 
	
   



   

ﬂ

   I
B




   

    	     
 
	
   



   

ﬂ

   I
B




   

    	     
 
	
  
 



   

ﬂ

     
B
 



   

       
 
	
  
 



   

ﬂ

     
B
 



   

      	
Bibliography
[1] D.H. Anderson Compartmental Modeling and Tracer Kinetics. Lecture Notes in Biomathe-
matics. Volume 50, Springer. ISBN 3-540-12303-2, (1983).
[2] K.G. Andersson and L-C. Bo¨iers Ordina¨ra differentialekvationer. Studentlitteratur, ISBN
91-44-29952-4, (1992).
[3] U.M. Ascher and L.R. Petzold Computer Methods for Ordinary Differential Equations and
Differtial-Algebraic Equations. SIAM, ISBN 0-89871-412-5, (1998).
[4] Y. Bard Nonlinear Parameter Estimation Academic Press, ISBN 0-12-078250-2, (1974).
[5] N.R. Draper and H. Smith Applied Regression Analysis Third Edition, Wiley, ISBN 0-471-
17082-8, (1998).
[6] B.A. Griffin and C.J. Packard Metabolism of VLDL and LDL subclass. Current Opinion
in Lipidology. Volume 5, p 200-206. Arterioscler Thromb Vasc Biol. Volume 21, p 1494-
1500, (1994).
[7] R.B. Kellogg and A.B. Stephens Complex Eigenvalues of a Non-Negative Matrix with a Spec-
ified Graph. Linear Algebra and its Applications. Volume 20, p 179-187, (1978).
[8] R. Malmstro¨m Acute regulation of VLDL APO B METABOLISM in healthy subjects and in
patients with type 2 diabetes. PhD thesis, ISBN 952-91-0689-0, (1999).
[9] C. J. Packard et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL sub-
fractions. Journal of lipid research. Volume 41, p 305-317, (2000).
[10] C.J. Packard, A. Gaw, T. Demant and J. Shepherd Development and application of a multi-
compartmental model to study very low density lipoprotein subfraction metabolism. Journal of
Lipid Research. Volume 36, p 172-187, (1995).
[11] F. Pont, L. Duvillard, B. Verge`s and P. Gambert Development of Compartmental Models
in Stable Isotope Experiments Application to Lipid Metabolism. Arterioscler Thromb Vasc Biol.
Volume 17, p 853-860, (1998).
[12] G.A.F. Seber and C.J. Wild Nonlinear Regression. Wiley, ISBN 0-471-61760-1, (1989).
[13] K. Tomiyasu et al. Differential Metabolism of Human VLDL According to Content of ApoE
and ApoC-III. Arterioscler Thromb Vasc Biol. Volume 21, p 1494-1500, (2001).
[14] D.E. Vance and J. Vance (editors)Biochemistry of Lipids, Lipoproteins and Membranes. New
Comprehencive Biochemistry. Volume 31. ELSEVIER, ISBN 0-444-82364-6, (1996).
56
BIBLIOGRAPHY 57
[15] D. White and M. Baxter (editors)Hormones And Metabolic Control. Second edition, ISBN
0-340-56355-9, (1994).
[16] L.A. Zech, S.M. Grundy, D. Steinberg and M. Berman Kinetic Model for Production and
Metabolism of Very Low Density Lipoprotein Triglycerides. Journal of Clinical Investigation.
Volume 63, p 1262-1273, (1979).
[17] SAAMII user guide. SAAM Institute, Inc., Seattle, WA. (1998).
